Evidence map›Paper›PMID 37569903›Full record

ReviewInternational journal of molecular sciences2023

Tackling Sleeping Sickness: Current and Promising Therapeutics and Treatment Strategies.

Miebaka Jamabo, Maduma Mahlalela, Adrienne L Edkins, Aileen Boshoff

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Fexinidazole and Corallopyronin A targetbioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Modern Strategies for Diagnosis and Treatment of Parasitic Diseases.International journal of molecular sciences · 2024
    Article
  12. Targeting Trypanothione Metabolism in Trypanosomatids.Molecules (Basel, Switzerland) · 2024
    Review
  13. Review
  14. Frontiers in microbiology · 2024
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Miebaka JamaboBiotechnology Innovation Centre, Rhodes University, Makhanda 6139, South Africa.ORCID 0000-0001-6386-1914
Maduma MahlalelaBiotechnology Innovation Centre, Rhodes University, Makhanda 6139, South Africa.ORCID 0000-0003-1514-3226
Adrienne L EdkinsDepartment of Biochemistry and Microbiology, Biomedical Biotechnology Research Centre (BioBRU), Rhodes University, Makhanda 6139, South Africa.ORCID 0000-0002-3615-6651
Aileen BoshoffBiotechnology Innovation Centre, Rhodes University, Makhanda 6139, South Africa.ORCID 0000-0001-6551-8941
Rhodes University · ZA

Funding

National research Foundation 129262National Research Foundation 98566
6 · The paper itself

Abstract

Human African trypanosomiasis is a neglected tropical disease caused by the extracellular protozoan parasite

Indexed as

COVID-19TrypanosomaTrypanosoma brucei bruceiTrypanosomiasis, AfricanAnimalsHumansPandemicsAfrican trypanosomiasisCOVID-19drug discoverydrug resistancedrug targetsleeping sicknessTrypanosoma brucei

Identifiers

PMID37569903
PMCPMC10420020
OpenAlexW4385778729

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.